Analyst
Moelis & Company
Equibles does not estimate personal net worth.
Tushar Mazudani is recorded as Analyst at Moelis & Company. Tushar Mazudani has spoken on 1 earnings call across 1 company, most recently for Cipla Limited on July 23, 2026. The companies whose calls Tushar Mazudani spoke on are classified in the Healthcare sector.
“So, just on this potential peptide product, the launch is subject to or contingent on any litigation or patent expiry or the product pure simple approval from the S&D.”
Moelis & Company
Analyst
Transcript header (unverified)
Cipla Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Cipla Limited
